Novavax (NVAX) EBITDA Margin (QoQ) (2010 - 2026)
Novavax (NVAX) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,073.00 |
| Dec 31, 2025 | 26,238.00 |
| Sep 30, 2025 | -31,046.00 |
| Jun 30, 2025 | -1,957.00 |
| Mar 31, 2025 | 22,576.00 |
| Dec 31, 2024 | 1,015.00 |
| Sep 30, 2024 | -19,733.00 |
| Jun 30, 2024 | 19,306.00 |
| Mar 31, 2024 | -9,131.00 |
| Dec 31, 2023 | 418.00 |
| Sep 30, 2023 | -8,025.00 |
| Jun 30, 2023 | 39,943.00 |
| Mar 31, 2023 | -31,813.00 |
| Dec 31, 2022 | -5,092.00 |
| Sep 30, 2022 | 24,245.00 |
| Jun 30, 2022 | -28,949.00 |
| Mar 31, 2022 | 40,100.00 |
| Dec 31, 2021 | -19,954.00 |
| Sep 30, 2021 | -5,570.00 |
| Jun 30, 2021 | -6,939.00 |